Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
lei 67.31
lei 6058.04lei 67.31
lei 807.32
60 tablet
Free AirMail shipping Hot
lei 71.80
lei 4307.87lei 71.80
lei 269.03
30 tablet
Free AirMail shipping Hot
lei 76.28
lei 2288.45lei 76.28
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
lei 80.77
lei 7269.69lei 80.77
lei 403.44
60 tablet
Free AirMail shipping Hot
lei 83.02
lei 4981.01lei 83.02
lei 134.40
30 tablet
Free AirMail shipping Hot
lei 85.26
lei 2557.71lei 85.26
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
lei 96.48
lei 8683.28lei 96.48
lei 403.44
60 tablet
Free AirMail shipping Hot
lei 98.72
lei 5923.41lei 98.72
lei 134.40
30 tablet
Free AirMail shipping Hot
lei 100.96
lei 3028.91lei 100.96
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.